Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104418507 | 10441850 | 7 | F | 201403 | 20160908 | 20140909 | 20160912 | EXP | US-GLAXOSMITHKLINE-A1048693A | GLAXOSMITHKLINE | 79.67 | YR | F | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104418507 | 10441850 | 1 | PS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | Y | 2ZP8461 | 21077 | 1 | DF | INHALATION POWDER | BID | ||||
104418507 | 10441850 | 2 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | U | 0 | |||||||||||
104418507 | 10441850 | 3 | SS | COREG | CARVEDILOL | 1 | Oral | 25 MG TABLET. | 012005212 | 0 | 25 | MG | TABLET | BID | |||||
104418507 | 10441850 | 4 | SS | COREG | CARVEDILOL | 1 | UNK | UNKNOWN | 0 | TABLET | |||||||||
104418507 | 10441850 | 5 | SS | COREG | CARVEDILOL | 1 | Unknown | 12.5 MG, U | 0 | 12.5 | MG | TABLET | |||||||
104418507 | 10441850 | 6 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 0 | |||||||||||
104418507 | 10441850 | 7 | SS | Morphine | MORPHINE | 1 | Unknown | U | 0 | ||||||||||
104418507 | 10441850 | 8 | SS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | Y | UNKNOWN | 0 | TABLET | ||||||||
104418507 | 10441850 | 9 | SS | CARVEDILOL. | CARVEDILOL | 1 | U | 0 | |||||||||||
104418507 | 10441850 | 10 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | ||||||||||||
104418507 | 10441850 | 11 | C | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | 1 | 0 | ||||||||||||
104418507 | 10441850 | 12 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
104418507 | 10441850 | 13 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
104418507 | 10441850 | 14 | C | COZAAR | LOSARTAN POTASSIUM | 1 | 0 | ||||||||||||
104418507 | 10441850 | 15 | C | NEURONTIN | GABAPENTIN | 1 | 0 | ||||||||||||
104418507 | 10441850 | 16 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
104418507 | 10441850 | 17 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | ||||||||||||
104418507 | 10441850 | 18 | C | NOVOLOG | INSULIN ASPART | 1 | 0 | ||||||||||||
104418507 | 10441850 | 19 | C | Baby aspirin | ASPIRIN | 1 | 0 | ||||||||||||
104418507 | 10441850 | 20 | C | TYLENOL ARTHRITIS PAIN | ACETAMINOPHEN | 1 | 0 | ||||||||||||
104418507 | 10441850 | 21 | C | TRAMADOL HCL | TRAMADOL HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
104418507 | 10441850 | 1 | Chronic obstructive pulmonary disease |
104418507 | 10441850 | 2 | Chronic obstructive pulmonary disease |
104418507 | 10441850 | 3 | Cardiac disorder |
104418507 | 10441850 | 6 | Product used for unknown indication |
104418507 | 10441850 | 7 | Pain |
104418507 | 10441850 | 8 | Cardiac ventricular thrombosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
104418507 | 10441850 | OT |
104418507 | 10441850 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
104418507 | 10441850 | Adverse event | |
104418507 | 10441850 | Amnesia | |
104418507 | 10441850 | Asthenia | |
104418507 | 10441850 | Atrial fibrillation | |
104418507 | 10441850 | Cardiac ventricular thrombosis | |
104418507 | 10441850 | Cerebrovascular accident | |
104418507 | 10441850 | Contusion | |
104418507 | 10441850 | Drug hypersensitivity | |
104418507 | 10441850 | Drug ineffective | |
104418507 | 10441850 | Dysarthria | |
104418507 | 10441850 | Dysgraphia | |
104418507 | 10441850 | Dysphonia | |
104418507 | 10441850 | Extremity necrosis | |
104418507 | 10441850 | Haemorrhage | |
104418507 | 10441850 | Hospitalisation | |
104418507 | 10441850 | Ill-defined disorder | |
104418507 | 10441850 | Infection | |
104418507 | 10441850 | Joint crepitation | |
104418507 | 10441850 | Lung disorder | |
104418507 | 10441850 | Malaise | |
104418507 | 10441850 | Memory impairment | |
104418507 | 10441850 | Micturition urgency | |
104418507 | 10441850 | Musculoskeletal disorder | |
104418507 | 10441850 | Neuropathy peripheral | |
104418507 | 10441850 | Oxygen saturation decreased | |
104418507 | 10441850 | Pain in extremity | |
104418507 | 10441850 | Peripheral swelling | |
104418507 | 10441850 | Surgery | |
104418507 | 10441850 | Swelling face | |
104418507 | 10441850 | Toxicity to various agents | |
104418507 | 10441850 | Transient ischaemic attack | |
104418507 | 10441850 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
104418507 | 10441850 | 3 | 2005 | 0 | ||
104418507 | 10441850 | 4 | 20081204 | 0 |